FcyRIIB is a novel immune checkpoint in the tumor microenvironment limiting activity of Treg-targeting antibodies

Supporters

Support the authors with ResearchCoin

Tip RSC

Preprint Server

Topics

#biology#immunology#medicine#internal-medicine#immune-checkpoint

Show all topics

DOI

10.1101/2023.01.19.522856

License

CC-BY-NC-ND

Other Formats

PDF